Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Super-refractory Status Epilepticus”

7 trials

Showing 7 of 7 results

Not applicableNo Longer AvailableNCT02433314
What this trial is testing

An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Who this might be right for
Super-Refractory Status Epilepticus
Supernus Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT07496749
What this trial is testing

KD Treatment for Super-refractory Status Epilepticus

Who this might be right for
Super-refractory Status Epilepticus
Xuanwu Hospital, Beijing 84
Testing effectiveness (Phase 2)Study completedNCT02052739
What this trial is testing

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Who this might be right for
Super-refractory Status Epilepticus
Supernus Pharmaceuticals, Inc. 25
Not applicableEnded earlyNCT03819543
What this trial is testing

SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus

Who this might be right for
Status Epilepticus
University of Manitoba 10
Not applicableStudy completedNCT05830864
What this trial is testing

Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Hopital of Melun 66
Large-scale testing (Phase 3)Study completedNCT02477618
What this trial is testing

A Study With SAGE-547 for Super-Refractory Status Epilepticus

Who this might be right for
Super-Refractory Status Epilepticus
Supernus Pharmaceuticals, Inc. 132
Not applicableStudy completedNCT05756621
What this trial is testing

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Who this might be right for
Status EpilepticusCardiac Arrest
University of Milano Bicocca 84

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation